Xu, M., Kong, Y., Chen, R., Xing, P., Zhang, J., Zhao, X., Zhang, L. (2025). RC48-ADC combined with radiotherapy and immunotherapy as salvage therapy for advanced solid tumors with HER2 expression: A multicenter, phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3032